Dr. Hönle AG

euro adhoc: Dr. Hönle AG
Quarterly or Semiannual Financial Statements
Hönle continues on a strong course of growth (E)

--------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. ---------------------------------------------------------------------

Gräfelfing/Munich, 14  August, 2003

Hönle (ISIN: DE 0005157101), a leading provider of industrial UV technology systems, has succeeded in continuing its course of growth as from the beginning of the financial year.  Quarterly sales increased by 30 percent in comparison to the previous year’s quarter. Overall, sales for the first three quarters were TEUR 11,744 or 21 percent up on the previous year’s quarter.

The Group’s income figures were also further expanded both in comparison to the second quarter of the current financial year as well as in comparison to the previous year’s period. EBIT rose from TEUR -866 in the previous year to TEUR 537 in the first nine months of the current financial year. In view of the still restrained demand for capital goods, the Group considers its present business development with a 5 percent EBIT margin to be positive. In comparison to the same period in the previous year, EBT and net income saw a rise from TEUR  -392 and TEUR -249 respectively to TEUR 995 and TEUR 1,049. Relative to 5.24 million shares, earnings per share climbed from EUR -0.05 in the previous year to EUR 0.20 this year.

The Hönle Group is still very solidly financed: the capital ratio is 86 percent. Liquid funds amount to TEUR 14,864 as at 30 June 2003, and financial assets are TEUR 579; this corresponds to an equivalent value of EUR 2.95 per share.

Outlook The third quarter was characterized by a strong increase in incoming orders. At the end of June 2003, the Dr. Hönle AG order volume was the highest ever in the 27 years of the firm’s history. We therefore expect that the fourth quarter will perform best in this financial year and that the results at year-end will probably be significantly up on those of the end of the third quarter. Among other things, the newly acquired key accounts are expected to make a positive contribution to sales and income development in the coming financial year.

end of announcement            euro adhoc 14.08.2003

Further inquiry note: Peter Weinert Tel.: +49 (0)89 856 08 173 E-Mail: peter.weinert@hoenle.de www.hoenle.de

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Prime Standard, Technologie All Share
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              Niedersächsische Börse zu Hannover / free trade
              Berliner Wertpapierbörse / free trade
              Bayerische Börse / free trade
              Hamburger Wertpapierbörse / free trade
              Bremer Wertpapierbörse (BWB) / free trade
              Börse Düsseldorf / free trade
              Baden-Württembergische Wertpapierbörse / free trade

Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: